Zum Hauptinhalt springen

Forschungsförderungsfonds Projekte

Der SFU MED Forschungsförderungsfonds fördert die medizinische Grundlagenforschung sowie ausgewählte klinische Forschung („translational research“) mit eindeutiger Affinität zur SFU MED.

Projekte des Forschungsförderungsfonds 2022-2023

Univ.-Prof. Dr. Christoph Baumgartner

Anfallsdetektion mit multimodalen Wearables bei therapieresistenter Epilepsie und psychogenen nicht-epileptischen (dissoziativen) Anfällen

Univ.-Prof. Dr. Sylvia Hartl und Dr. Marie-Katrin Breyer

Tuberkulose-Register: Registerstudie in Österreich

Univ.-Prof. Dr. Sylvia Hartl und Dr. Marie-Katrin Breyer

Allergen profiling of asthma subjects within the LEAD Study

Univ.-Prof. Dr. Sylvia Hartl und Dr. Marie-Katrin Breyer

The role of microalbuminuria in (Pre)diabetes in the Austrian General Population

Univ.-Prof. Dr. Sylvia Hartl und Dr. Marie-Katrin Breyer

Early, non-invasive diagnosis of lung cancer by testing for viral biomarkers in exhaled breath air

Univ.-Prof. Dr. Kurt Huber und Dr. Achim Burger

POESIA – an exploratory Study. Pleiotropic effects of PCSK 9 inhibition and bempodoic acid

Univ.-Prof. Dr. Klaus Geissler

Epithelial-hematopoietic transition: implications for oncology and developmental biology

Univ.-Prof. Dr. Kurt Huber und Univ.-Prof. Dr. Manuel Mayr

Harnessing Proteomics and Machine Learning for Subtypes of Myocardial Infarction

Univ.-Prof. Dr. Kurt Huber und Dr. med. univ. Benjamin Panzer

Influence of SGLT-2 inhibitors on cardiac remodelling and pleiomorphic effects on biomarkers in patients with reduce, mid-range and preserved ejectin fraction

Univ.-Prof. Dr. Thomas Grünberger und Dr. Jonas Santol

The Influence of Bacterial Translocation on the Oncologic Outcome of HCC Patients after Liver Resection – a Multi-Omics Approach

Univ.-Prof. Dr. Alexandra Schosser

Genome-wide therapygenetic study of a large international Borderline Personality Disorder RCT

Univ.-Prof. Dr. Martin Grabenwöger und Dr. Thomas Aschacher

Effects of aortic telocytes and their regulatory function on smooth muscle cells in aortic aneurysm development

Univ.-Prof. Dr. Martin Grabenwöger und Dr. Bernhard Winkler

Analysis of different preservation solutions for arterial and venous bypass grafting – PRESAVE Study

Projekte des Forschungsförderungsfonds 2023-2024

Univ.-Prof. Dr. Sibylle Langenecker und Dipl. Ing. Isabella Rostocki

Untersuchungen zur Glykokalyx

Univ.-Prof. Dr. Alexandra Schosser

Follow-up Sequencing of BDNF as Psychotherapeutic Treatment Response Biomarker in the VieSAD (Vienna Study on Genetics of Suicide in Affective Disorders, FWF KLIF°220) Study

Dr. med. univ. Louisa Hempel

VHL Victory: Targeting HIF-2α in Neuroendocrine Tumor Therapy „Exploring the Efficacy of hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor Treating Neuroendocrine Tumors Associated with von Hippel–Lindau Disease.“

Dr. Christoph Kaufmann und Dr. Achim Burger

Biomarkers in patients with Atrial Fibrillation undergoing Pulmonary Vein Isolation – the prospective Bio-PVI registry

Dr. Christoph Kaufmann und Dr. Achim Burger

Biomarkers in patients with Atrial Fibrillation undergoing Pulmonary Vein Isolation – the prospective Bio-ICD registry

Univ.-Prof. Dr. Kurt Huber und Dr. med. univ. Benjamin Panzer

Influence of SGLT-2 inhibitors on in vitro platelet function in combination with a potent P2Y12 inhibitor

Univ.-Prof. Dr. Kurt Huber und Dr. Edita Pogran

LDL-C/Apolipoprotein B ratio in patients with acute coronary syndrome: a retrospective observational case controll study

Univ.-Prof. Dr. Thomas Grünberger und Dr. Jonas Santol

The Effect of MicroRNA-122 Inhibition on Postoperative Liver Regeneration in Mice

Univ.-Prof. Dr. Christian Fialka

Comparison of clinical outcome data vs. Patient Reported Outcome Measures (PROMS) in rotator cuff repair in cases of workman´s compensation

Univ.-Prof. Dr. Martin Grabenwöger und Dr. Thomas Aschacher

Clinical benefits, safety and efficiency of conduction system pacing in patients requiring pacemaker implantation – A single-centre, non-randomized observational trail (TACIT-Trial)

Univ.-Prof. Dr. Alexander Zoufaly und Dr. Max Augustin

2Long4COVID: Cross-sectional study of the innate and acquired immunity in the gut-specific lymphoid tissue (GALT) in SARS-CoV-2 convalescents with and without Post-COVID syndrome (PCS) and coronanaive controls

Dr. Andreas Schober

,,LeanAwake TAVI“ (LeanAwake Transkatheter Aortenklappen Implantation) – eine neue Strategie zum periinterventionellen Management und Vermeidung von Delir bei transfemoraler TAVI

Dr. Marie-Kathrin Breyer

Investigating the Prevalence and Clinical Characteristics of Heart Failure (HFpEF & HFmrEF) in Individuals with Early Pulmonary Impairments: Insights from the Austrian LEAD Study

Univ.-Prof. Dr. Kurt Huber und Dr. Patrick Welter

Monocyte subsets and cardiovascular biomarkers as potential new noninvasive markers for differentiation between type 1 and type 2 myocardial infarction – an exploratory study.

Projekte des Forschungsförderungsfonds 2024-2025

Projekte des Forschungsförderungsfonds 2024-2025

Univ.-Prof. DDr. Barbara Cvikl

Analyzing the effect of different air-polishing powders on oral cells

Univ.-Prof. Dr. Kurt Huber und PD Dr. Andreas Leiherer

Predicting Coronary Artery Disease and Cardiovascular Events in High-Risk Patietns Using Machine Learning on Omics Data

Univ.-Prof. Dr. Wilfried Lang und DDr. Robert Wakolbinger-Habel

Pilotprojekt Osteoporose-Management nach Schlaganfall

Univ.-Prof. Dr. Thomas Grünberger und Dr. Yawn Dong

Aberrant TGF-ß signaling as a target for immune therapy in hepatocellular carcinoma

Univ.-Prof. Dr. Horst Olschewski

Effects of hypoxia on pulmonary angiocrine factors

Univ.-Prof. Dr. Christoph Baumgartner

Biomarker für Sudden Death bei Epilepsie

Univ.-Prof. Dr. Kurt Huber und Univ.-Prof. Dr. Manuel Mayr

Validation of Proteomics Findings for Subtypes of Myocardial Infarction

Assoz.-Prof. Priv.- Doz. Dr. Roland Kocijan

Implementation of Osteoporotic Radius Fractures into the Fracture Liaison Service (FLS)

Univ.-Prof. Dr. Otto C. Burghuber und Univ.-Prof. Dr. Sylvia Hartl

IL33 pathways in individuals with early pulmonary impairment – impact on cardiovascular health

Univ.-Prof. Dr. Heinrich Resch

Metabolomics Profiling and Bone Metabolism: A Comprehensive Study on Anorexia Nervosa and Osteoporosis

PD DDr. Martin Grübler

Development of a chimeric antigen receptor T-cell therapy against cardiac sarcoidosis targeting granuloma formation

zum Seitenanfang